Oblon is headquartered within steps of the United States Patent and Trademark Office (USPTO), and has an affiliate office in Tokyo, Japan. Oblon is…
Oblon | USA | 16 May 2023
The Patent Trial and Appeals Board denied U.S. Well Services, LLC’s (the Patent Owner) Motion to Amend the claims of U.S. Patent No. 10,254,732 B2…
Oblon | USA | 15 May 2023
Today the Supreme Court denied cert in GSK v. Teva in which the Solicitor General filed a brief in support of granting cert. The Solicitor argued…
Oblon | USA | 12 May 2023
On April 28 the Supreme Court heard oral arguments on Amgen’s petition of the Federal Circuit’s decision affirming the district court’s decision on…
Oblon | USA | 11 May 2023
On May 2, 2023, the Patent Trial and Appeal Board (PTAB) reversed the Examiner’s rejection of a claim directed to a method of creating an immobilized…
Oblon | USA | 11 May 2023
In the April 29, 2023 article, the Yomiuri Shimbun reported that a group of creative artists met with government official to discuss legal…
Press release
Oblon | USA | 20 Apr 2023
Yuki Onoe, Partner, Head of Oblon's Tokyo office, member of the Management Committee, co-chair of the Chemical practice group, and member of the Life…
Oblon | USA | 20 Apr 2023
The USPTO today announced Advance Notice of Proposed Rulemaking for PTAB reforms regarding IPRs/PGRs. The proposal related to five areas: Key Area 1:…
Press release
Oblon | Japan | 17 Apr 2023
The Japan Patent Office has recently updated “The JPO Key Features,” a section of its website that introduces the benefits of filing applications in…